6.
Guy R, Henderson K, Coelho J, Hughes H, Mason E, Gerver S
. Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023; 28(1).
PMC: 9817207.
DOI: 10.2807/1560-7917.ES.2023.28.1.2200942.
View
7.
Rodriguez-Ruiz J, Lin Q, Lammens C, Smeesters P, Koeveringe S, Matheeussen V
. Increase in bloodstream infections caused by 1 group A correlates with emergence of toxigenic M1, Belgium, May 2022 to August 2023. Euro Surveill. 2023; 28(36).
PMC: 10486196.
DOI: 10.2807/1560-7917.ES.2023.28.36.2300422.
View
8.
Li Y, Rivers J, Mathis S, Li Z, Chochua S, Metcalf B
. Expansion of Invasive Group A Streptococcus M1 Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021. Emerg Infect Dis. 2023; 29(10):2116-2120.
PMC: 10521608.
DOI: 10.3201/eid2910.230675.
View
9.
Tonkin-Hill G, MacAlasdair N, Ruis C, Weimann A, Horesh G, Lees J
. Producing polished prokaryotic pangenomes with the Panaroo pipeline. Genome Biol. 2020; 21(1):180.
PMC: 7376924.
DOI: 10.1186/s13059-020-02090-4.
View
10.
Johannesen T, Munkstrup C, Edslev S, Baig S, Nielsen S, Funk T
. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent M1 clone, Denmark, 2023. Euro Surveill. 2023; 28(26).
PMC: 10311951.
DOI: 10.2807/1560-7917.ES.2023.28.26.2300291.
View
11.
Golden A, Griffith A, Tyrrell G, Kus J, McGeer A, Domingo M
. Invasive group A streptococcal disease surveillance in Canada, 2021-2022. Can Commun Dis Rep. 2024; 50(5):135-143.
PMC: 11149783.
DOI: 10.14745/ccdr.v50i05a03.
View
12.
Frost H, Davies M, Velusamy S, Delforge V, Erhart A, Darboe S
. Updated emm-typing protocol for Streptococcus pyogenes. Clin Microbiol Infect. 2020; 26(7):946.e5-946.e8.
DOI: 10.1016/j.cmi.2020.02.026.
View
13.
Vieira A, Wan Y, Ryan Y, Li H, Guy R, Papangeli M
. Rapid expansion and international spread of M1 in the post-pandemic UK upsurge of Streptococcus pyogenes. Nat Commun. 2024; 15(1):3916.
PMC: 11087535.
DOI: 10.1038/s41467-024-47929-7.
View
14.
Davies P, Russell C, Morgan A, Taori S, Lindsay D, Ure R
. Increase of Severe Pulmonary Infections in Adults Caused by M1 Streptococcus pyogenes, Central Scotland, UK. Emerg Infect Dis. 2023; 29(8):1638-1642.
PMC: 10370863.
DOI: 10.3201/eid2908.230569.
View
15.
Frost H, Guglielmini J, Duchene S, Lacey J, Sanderson-Smith M, Steer A
. Promiscuous evolution of Group A Streptococcal M and M-like proteins. Microbiology (Reading). 2023; 169(1).
PMC: 9993116.
DOI: 10.1099/mic.0.001280.
View
16.
Brouwer S, Rivera-Hernandez T, Curren B, Harbison-Price N, De Oliveira D, Jespersen M
. Pathogenesis, epidemiology and control of Group A Streptococcus infection. Nat Rev Microbiol. 2023; 21(7):431-447.
PMC: 9998027.
DOI: 10.1038/s41579-023-00865-7.
View
17.
Alcolea-Medina A, Snell L, Alder C, Charalampous T, Williams T, Tan M
. The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study. Clin Microbiol Infect. 2023; 29(7):887-890.
PMC: 10769882.
DOI: 10.1016/j.cmi.2023.03.001.
View
18.
Aboulhosn A, Sanson M, Vega L, Segura M, Summer L, Joseph M
. Increases in group A streptococcal infections in the pediatric population in Houston, TX, 2022. Clin Infect Dis. 2023; .
PMC: 10425190.
DOI: 10.1093/cid/ciad197.
View
19.
Lynskey N, Jauneikaite E, Li H, Zhi X, Turner C, Mosavie M
. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019; 19(11):1209-1218.
PMC: 6838661.
DOI: 10.1016/S1473-3099(19)30446-3.
View
20.
Kasper K, Zeppa J, Wakabayashi A, Xu S, Mazzuca D, Welch I
. Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner. PLoS Pathog. 2014; 10(5):e1004155.
PMC: 4038607.
DOI: 10.1371/journal.ppat.1004155.
View